Labelling of manganese-based magnetic resonance imaging (MRI) contrast agents with the positron emitter 51Mn, as exemplified by manganese-tetraphenyl-porphin-sulfonate (MnTPPS4)

Appl Radiat Isot. 2005 May;62(5):711-20. doi: 10.1016/j.apradiso.2004.09.009.

Abstract

The potential tumor seeking MRI contrast agent MnTPPS(4) was labelled with the positron emitting nuclide (51)Mn in no-carrier-added (n.c.a.) form. The complex formation kinetics were investigated and the apparent rate constants were determined under pseudo-first-order conditions. The derived bimolecular rate constants gave the Arrhenius parameters E(A)=84 kJ mol(-1) and A=2 x 10(12)s(-1)M(-1). Optimum labelling conditions were derived (radiochemical yields >99% possible, effective yields about 32%). Separation and purification of n.c.a. (51)MnTPPS(4) were performed for potential human use. All impurities were <1%.

MeSH terms

  • Contrast Media / chemistry*
  • Humans
  • Kinetics
  • Magnetic Resonance Imaging*
  • Manganese / chemistry*
  • Neoplasms / diagnosis
  • Porphyrins / chemistry*
  • Porphyrins / isolation & purification

Substances

  • Contrast Media
  • Porphyrins
  • tetraphenylporphine sulfonate
  • Manganese